Dr Timothy Daniel Shub, MD | |
34 Maple St, Norwalk, CT 06850-3894 | |
(203) 852-2000 | |
Not Available |
Full Name | Dr Timothy Daniel Shub |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 34 Maple St, Norwalk, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013477538 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 69607 (Connecticut) | Primary |
Entity Name | Danbury Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548293343 PECOS PAC ID: 1557273935 Enrollment ID: O20031104000476 |
News Archive
AutoImmune Inc. today announced that its Board of Directors has authorized the exploration of a full range of strategic alternatives available to the Company in order to enhance shareholder value. AutoImmune has retained Junewicz & Co. as its financial advisor for this evaluation process.
United Medical Systems announces the acquisition of MoBx Mobile Breast Services, a Vacaville, California-based company for an undisclosed cash amount. The acquisition expands UMS' stereotactic operations throughout Northern California. United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states and South America.
Perle Bioscience, Inc. announces enrollment for the Insulin Independence Trial (IIT). This trial is the first and only Phase 3 trial to test a combination therapy in type 1 diabetics.
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
› Verified 7 days ago
Entity Name | Nuvance Health Medical Practice Ct Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
AutoImmune Inc. today announced that its Board of Directors has authorized the exploration of a full range of strategic alternatives available to the Company in order to enhance shareholder value. AutoImmune has retained Junewicz & Co. as its financial advisor for this evaluation process.
United Medical Systems announces the acquisition of MoBx Mobile Breast Services, a Vacaville, California-based company for an undisclosed cash amount. The acquisition expands UMS' stereotactic operations throughout Northern California. United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states and South America.
Perle Bioscience, Inc. announces enrollment for the Insulin Independence Trial (IIT). This trial is the first and only Phase 3 trial to test a combination therapy in type 1 diabetics.
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
› Verified 7 days ago
Entity Name | Norwalk Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427041581 PECOS PAC ID: 3375436660 Enrollment ID: O20040202000988 |
News Archive
AutoImmune Inc. today announced that its Board of Directors has authorized the exploration of a full range of strategic alternatives available to the Company in order to enhance shareholder value. AutoImmune has retained Junewicz & Co. as its financial advisor for this evaluation process.
United Medical Systems announces the acquisition of MoBx Mobile Breast Services, a Vacaville, California-based company for an undisclosed cash amount. The acquisition expands UMS' stereotactic operations throughout Northern California. United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states and South America.
Perle Bioscience, Inc. announces enrollment for the Insulin Independence Trial (IIT). This trial is the first and only Phase 3 trial to test a combination therapy in type 1 diabetics.
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
› Verified 7 days ago
Entity Name | Emergency Physicians Of Connecticut Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902278906 PECOS PAC ID: 8820390214 Enrollment ID: O20151231000158 |
News Archive
AutoImmune Inc. today announced that its Board of Directors has authorized the exploration of a full range of strategic alternatives available to the Company in order to enhance shareholder value. AutoImmune has retained Junewicz & Co. as its financial advisor for this evaluation process.
United Medical Systems announces the acquisition of MoBx Mobile Breast Services, a Vacaville, California-based company for an undisclosed cash amount. The acquisition expands UMS' stereotactic operations throughout Northern California. United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states and South America.
Perle Bioscience, Inc. announces enrollment for the Insulin Independence Trial (IIT). This trial is the first and only Phase 3 trial to test a combination therapy in type 1 diabetics.
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
› Verified 7 days ago
Entity Name | Emergency Care Services Of Connecticut Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518519461 PECOS PAC ID: 0042541229 Enrollment ID: O20191021000580 |
News Archive
AutoImmune Inc. today announced that its Board of Directors has authorized the exploration of a full range of strategic alternatives available to the Company in order to enhance shareholder value. AutoImmune has retained Junewicz & Co. as its financial advisor for this evaluation process.
United Medical Systems announces the acquisition of MoBx Mobile Breast Services, a Vacaville, California-based company for an undisclosed cash amount. The acquisition expands UMS' stereotactic operations throughout Northern California. United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states and South America.
Perle Bioscience, Inc. announces enrollment for the Insulin Independence Trial (IIT). This trial is the first and only Phase 3 trial to test a combination therapy in type 1 diabetics.
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Timothy Daniel Shub, MD 1706 Bushwick Ave, Merrick, NY 11566-2938 Ph: (347) 277-3691 | Dr Timothy Daniel Shub, MD 34 Maple St, Norwalk, CT 06850-3894 Ph: (203) 852-2000 |
News Archive
AutoImmune Inc. today announced that its Board of Directors has authorized the exploration of a full range of strategic alternatives available to the Company in order to enhance shareholder value. AutoImmune has retained Junewicz & Co. as its financial advisor for this evaluation process.
United Medical Systems announces the acquisition of MoBx Mobile Breast Services, a Vacaville, California-based company for an undisclosed cash amount. The acquisition expands UMS' stereotactic operations throughout Northern California. United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states and South America.
Perle Bioscience, Inc. announces enrollment for the Insulin Independence Trial (IIT). This trial is the first and only Phase 3 trial to test a combination therapy in type 1 diabetics.
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
› Verified 7 days ago
Dr. Arthur Strichman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 34 Maple St, Norwalk, CT 06850 Phone: 203-852-2281 | |
Dr. Bharat Patel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 235 Main Ave, Norwalk, CT 06851 Phone: 203-847-2600 | |
Steven Gary Berger, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 346 Main Ave, Norwalk, CT 06851 Phone: 203-846-0005 Fax: 203-846-0012 | |
Dr. Jean Marie Hammel, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 24 Stevens Street, Norwalk Hospital Emergency Department, Norwalk, CT 06856 Phone: 203-852-2281 | |
Dr. Elizabeth Dt Kassapidis, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2281 | |
Dr. Richard J Teitell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2160 |